Clinical Trial Update: Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials evaluating selective photocoagulation for diabetic macular edema have completed (Phase 2 and Phase 3). The sponsor is Lumenis Be Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Selective Photocoagulation

Snippet

Sponsor: Lumenis Be Ltd. | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED